Latest News and Press Releases
Want to stay updated on the latest news?
-
OCEANSIDE, CA--(Marketwired - April 11, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an agreement between its subsidiary, MolecuVax, Inc.,...
-
OCEANSIDE, CA--(Marketwired - March 16, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) a public clinical stage company focused on immune modulation for the treatment of...
-
Therapeutic Solutions International Announces the Licensing of Exosome Technology to MolecuVax, Inc.
OCEANSIDE, CA--(Marketwired - February 08, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Company has licensed their Exosome Patent to MolecuVax,...
-
OCEANSIDE, CA--(Marketwired - January 25, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an exclusive intellectual property license agreement...
-
OCEANSIDE, CA--(Marketwired - January 22, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the appointment of Dr. Thomas E. Ichim to our Board of Directors. Dr....
-
OCEANSIDE, CA--(Marketwired - January 05, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Barry Glassman, DMD, DAAPM, DAACP, FICCMO, Diplomate ABDSM,...
-
OCEANSIDE, CA--(Marketwired - Dec 8, 2015) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed an additional Patent to OmniBiome, Inc....
-
OCEANSIDE, CA--(Marketwired - Nov 23, 2015) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today a patent for developing a future generation of immune cell derived...
-
OCEANSIDE, CA--(Marketwired - Nov 18, 2015) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed three Patents to OmniBiome, Inc....
-
OCEANSIDE, CA--(Marketwired - Oct 19, 2015) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Michael Agadjanyan, Ph.D. has been appointed to our Scientific...